These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32097657)

  • 1. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
    Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
    Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
    Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
    Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
    J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of TNF and IL-33 Cytokines on Mast Cells in Neuroinflammation.
    Conti P; Ronconi G; Lauritano D; Mastrangelo F; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Carinci F; Gaudelli F; Annicchiarico C; D'Ovidio C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
    Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
    Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
    Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.
    Conti P; Stellin L; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
    Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
    Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation.
    Wu Z; Zhang J; Nakanishi H
    J Neuroimmunol; 2005 Oct; 167(1-2):90-8. PubMed ID: 16095726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 family cytokines and mast cells: activation and inhibition.
    Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis.
    Zhang X; Dong H; Li N; Zhang S; Sun J; Zhang S; Qian Y
    J Neuroinflammation; 2016 May; 13(1):127. PubMed ID: 27245661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mold on mast cell-cytokine immune response.
    Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P
    J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
    Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
    Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.